China SMid Insurance/Banks: SMid players face a tougher survival test

Research evidence excerpt

China SMid Insurance/Banks: SMid players face a tougher survival test

Asia Pacific Equity Research

28 July 2026

China SMid Insurance/Banks

SMid players face a tougher survival test

The Matthew principle is set to accelerate market polarization across China’s Insurance

insurance sector, in our view (for details, see Market polarization risk rising as AC Dan Wang

smaller players face capital pressure, 28 July) Our three-dimensional framework

(86-21) 6106-6349

analyses 163 insurers, comprising 75 life and 88 non-life insurers, across three dan.wang@jpmorgan.com

core lenses: solvency strength, organic earnings capacity and shareholder-return SAC Registration Number: S1730524080001

visibility. The evidence points to a clear and widening divide. Smaller insurers are J.P. Morgan Securities (China) Company

structurally disadvantaged across all three pillars, while large-cap peers are Limited

increasingly positioned to consolidate market share and valuation premia. Within Haomin Chen AC

our insurance coverage, China Taiping and China Re stand out as key (86-21) 6106 6347

beneficiaries of this industry restructuring. A similar divergence is emerging haomin.chen@jpmorgan.com

among regional banks, where we continue to favor Bank of Ningbo, supported by SAC Registration Number: S1730524080002

resilient growth and stable asset quality. J.P. Morgan Securities (China) Company

Limited

• Lens #1: Capital strength and solvency resilience. Insurance is capital- MW Kim

intensive, and growth consumes capital. While large-cap insurers typically (852) 2800-8517

maintain core solvency ratios above 100%, 17 unlisted life insurers sit below mw.kim@jpmorgan.com

100%, signaling thin capital cushions. Core solvency alone, however, does not J.P.J.P.